Subtypes of receptors for serotonin.
暂无分享,去创建一个
[1] J. Gaddum,et al. TWO KINDS OF TRYPTAMINE RECEPTOR , 1997, British journal of pharmacology and chemotherapy.
[2] J. Williams,et al. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors. , 1989, The Journal of pharmacology and experimental therapeutics.
[3] R. North,et al. 5-HT3 receptors are membrane ion channels , 1989, Nature.
[4] T. Jessell,et al. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.
[5] G Vassart,et al. Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.
[6] J. A. Peters,et al. Electrophysiology of 5-HT3 receptors in neuronal cell lines. , 1989, Trends in pharmacological sciences.
[7] C. Strader,et al. Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] D. Middlemiss,et al. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. , 1989, Trends in pharmacological sciences.
[9] J. Bockaert,et al. BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons. , 1989, European journal of pharmacology.
[10] P. Hartig. Molecular biology of 5-HT receptors. , 1989, Trends in pharmacological sciences.
[11] M. Brann,et al. Localization of a family of muscarinic receptor mRNAs in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] E. sanders-Bush,et al. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. , 1988, The Journal of pharmacology and experimental therapeutics.
[13] B. Costall,et al. Identification of 5‐HT3 recognition sites in the ferret area postrema , 1988, The Journal of pharmacy and pharmacology.
[14] T. Jessell,et al. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. , 1988, Science.
[15] J. Bockaert,et al. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. , 1988, European journal of pharmacology.
[16] T. Bonner,et al. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes , 1988, Neuron.
[17] N. Ropert. Inhibitory action of serotonin in CA1 hippocampal neurons In vitro , 1988, Neuroscience.
[18] G. Aghajanian,et al. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurons , 1988, Neuropharmacology.
[19] C. Swain,et al. [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain. , 1988, European journal of pharmacology.
[20] B. Costall,et al. The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist , 1988, British journal of pharmacology.
[21] S. Peroutka,et al. [3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes. , 1988, European journal of pharmacology.
[22] H. Vijverberg,et al. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells , 1988, Neuropharmacology.
[23] J. Bockaert,et al. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. , 1988, Molecular pharmacology.
[24] J. Bockaert,et al. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. , 1988, European journal of pharmacology.
[25] G. Aghajanian,et al. Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. , 1987, European journal of pharmacology.
[26] R. Glennon,et al. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. , 1987, Biochemical pharmacology.
[27] E. Hansson,et al. 5-Hydroxytryptamine stimulates the formation of inositol phosphate in astrocytes from different regions of the brain , 1987, Neuropharmacology.
[28] M. Caron,et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins , 1987, Nature.
[29] G. Martin,et al. Differential classification of vascular smooth muscle and endothelial cell 5‐HT receptors by use of tryptamine analogues , 1987, British journal of pharmacology.
[30] M. Vivo,et al. Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate , 1987, Brain Research.
[31] H. van Belle,et al. Serotonin-induced alterations in inositol phospholipid metabolism in human platelets. , 1987, Biochimica et biophysica acta.
[32] M. Titeler,et al. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. , 1987, Molecular pharmacology.
[33] U. Leli,et al. Stimulation of Phosphoinositide Hydrolysis by Serotonin in C6 Glioma Cells , 1987, Journal of neurochemistry.
[34] T. Branchek,et al. Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[35] H. Meltzer,et al. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat Evidence for opposing roles of 5-HT2 and 5-HT1A receptors , 1986, Neuropharmacology.
[36] G. Aghajanian,et al. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists , 1986, Brain Research.
[37] C. de Montigny,et al. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] G. Allen,et al. Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors. , 1986, The Journal of pharmacology and experimental therapeutics.
[39] W. Feniuk,et al. 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. , 1986, Life sciences.
[40] M. Minchin,et al. Serotonergic agonists stimulate inositol lipid metabolism in rabbit platelets. , 1985, Life sciences.
[41] M. Hirata,et al. A role for inositol 1,4,5‐trisphosphate in the initiation of agonist‐induced contractions of dog tracheal smooth muscle , 1985, British journal of pharmacology.
[42] P. Conn,et al. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. , 1985, The Journal of pharmacology and experimental therapeutics.
[43] J. Leysen,et al. Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. , 1985, Journal of Biological Chemistry.
[44] R. Glennon,et al. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. , 1984, Life sciences.
[45] M. Titeler,et al. Guanyl Nucleotide and Divalent Cation Regulation of Cortical S2 Serotonin Receptors , 1984, Journal of neurochemistry.
[46] G. Aghajanian,et al. Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance , 1984, Brain Research.
[47] C. Wilkinson,et al. 5-Hydroxytryptamine receptor in rabbit aorta: characterization by butyrophenone analogs. , 1984, The Journal of pharmacology and experimental therapeutics.
[48] J. Glowinski,et al. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.
[49] J. Leysen. Serotonin receptor binding sites: is there pharmacological and clinical significance? , 1983, Medical biology.
[50] A. Closse. [3H]Mesulergine, a selective ligand for serotonin-2 receptors. , 1983, Life sciences.
[51] Herman Ag,et al. 5-hydroxytryptamine and platelet aggregation. , 1983 .
[52] Van Nueten Jm. 5-hydroxytryptamine and precapillary vessels. , 1983, Federation proceedings.
[53] Y. Saito,et al. 5-HT-stimulated arachidonic acid release from labeled phosphatidylinositol in blowfly salivary glands. , 1982, The American journal of physiology.
[54] P. Molinoff,et al. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. , 1981, Life sciences.
[55] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[56] R. Mccall,et al. Serotonergic facilitation of facial motoneuron excitation , 1979, Brain Research.
[57] J. Leysen,et al. A serotonergic component of neuroleptic receptors. , 1977, Archives internationales de pharmacodynamie et de therapie.
[58] S. O'Donnell,et al. THE CONTRIBUTION OF EXTRANEURONAL UPTAKE TO THE TRACHEA‐BLOOD VESSEL SELECTIVITY OF β‐ADRENOCEPTOR STIMULANTS in vitro IN GUINEA‐PIGS , 1976, British journal of pharmacology.
[59] H. van Vunakis,et al. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain. , 1973, Biochemical pharmacology.
[60] D. Grahame-Smith. STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.
[61] T. Rall,et al. The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum. , 1968, Molecular pharmacology.
[62] T. Rall,et al. Studies on adenosine 3',5'-phosphate in rabbit cerebral cortex. , 1968, Molecular pharmacology.
[63] G. Aston-Jones,et al. [Selective reduction by serotonin, of neuronal excitation in the locus coeruleus evoked by glutamate]. , 1988, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[64] M. Vivo,et al. 5-HT Receptors Coupled to Adenylate Cyclase , 1988 .
[65] G. Aghajanian,et al. Electrophysiology of Central Serotonin Receptor Subtypes , 1988 .
[66] M. Titeler,et al. Pharmacology and Biochemistry of the 5-HT2 Receptor , 1988 .
[67] E. Frohlich. The Role of Serotonin in Cardiovascular Disease , 1987, Journal of cardiovascular pharmacology.
[68] R. Iyengar,et al. Regulation of hormone receptors and adenylyl cyclases by guanine nucleotide binding N proteins. , 1985, Recent progress in hormone research.
[69] I. Lucki,et al. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.
[70] P. Greengard,et al. Serotonin stimulates phosphorylation of Protein I in the facial motor nucleus of rat brain , 1981, Nature.
[71] K. Fuxe,et al. EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.
[72] M. Rapport,et al. Purification of the substance which is responsible for the vasoconstrictor activity of serum. , 1947, Federation proceedings.